Fairchild CR - Search Results

1

Preclinical pharmacology of BMS-275183, an orally active taxane.

Rose WC, Long BH, Fairchild CR, Lee FY, Kadow JF. Rose WC, et al. Among authors: fairchild cr. Clin Cancer Res. 2001 Jul;7(7):2016-21. Clin Cancer Res. 2001. PMID: 11448919

2

Synthesis and biological activity of macrocyclic taxane analogues.

Tarrant JG, Cook D, Fairchild C, Kadow JF, Long BH, Rose WC, Vyas D. Tarrant JG, et al. Bioorg Med Chem Lett. 2004 May 17;14(10):2555-8. doi: 10.1016/j.bmcl.2004.02.086. Bioorg Med Chem Lett. 2004. PMID: 15109650

3

Antitumor and antiangiogenic activities of BMS-690514, an inhibitor of human EGF and VEGF receptor kinase families.

Wong TW, Lee FY, Emanuel S, Fairchild C, Fargnoli J, Fink B, Gavai A, Hammell A, Henley B, Hilt C, Hunt JT, Krishnan B, Kukral D, Lewin A, Malone H, Norris D, Oppenheimer S, Vite G, Yu C. Wong TW, et al. Clin Cancer Res. 2011 Jun 15;17(12):4031-41. doi: 10.1158/1078-0432.CCR-10-3417. Epub 2011 Apr 29. Clin Cancer Res. 2011. PMID: 21531814

4

The discovery of BMS-275183: an orally efficacious novel taxane.

Mastalerz H, Cook D, Fairchild CR, Hansel S, Johnson W, Kadow JF, Long BH, Rose WC, Tarrant J, Wu MJ, Xue MQ, Zhang G, Zoeckler M, Vyas DM. Mastalerz H, et al. Among authors: fairchild cr. Bioorg Med Chem. 2003 Oct 1;11(20):4315-23. doi: 10.1016/s0968-0896(03)00495-4. Bioorg Med Chem. 2003. PMID: 13129567

5

Synergistic antitumor activity of ixabepilone (BMS-247550) plus bevacizumab in multiple in vivo tumor models.

Lee FY, Covello KL, Castaneda S, Hawken DR, Kan D, Lewin A, Wen ML, Ryseck RP, Fairchild CR, Fargnoli J, Kramer R. Lee FY, et al. Among authors: fairchild cr. Clin Cancer Res. 2008 Dec 15;14(24):8123-31. doi: 10.1158/1078-0432.CCR-08-0025. Clin Cancer Res. 2008. PMID: 19088027

6

Paclitaxel inhibits progression of mitotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telephase.

Long BH, Fairchild CR. Long BH, et al. Among authors: fairchild cr. Cancer Res. 1994 Aug 15;54(16):4355-61. Cancer Res. 1994. PMID: 7913875

7

Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol).

Long BH, Carboni JM, Wasserman AJ, Cornell LA, Casazza AM, Jensen PR, Lindel T, Fenical W, Fairchild CR. Long BH, et al. Among authors: fairchild cr. Cancer Res. 1998 Mar 15;58(6):1111-5. Cancer Res. 1998. PMID: 9515790

8

BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.

Lee FY, Borzilleri R, Fairchild CR, Kim SH, Long BH, Reventos-Suarez C, Vite GD, Rose WC, Kramer RA. Lee FY, et al. Among authors: fairchild cr. Clin Cancer Res. 2001 May;7(5):1429-37. Clin Cancer Res. 2001. PMID: 11350914

9

Preclinical antitumor activity of BMS-214662, a highly apoptotic and novel farnesyltransferase inhibitor.

Rose WC, Lee FY, Fairchild CR, Lynch M, Monticello T, Kramer RA, Manne V. Rose WC, et al. Among authors: fairchild cr. Cancer Res. 2001 Oct 15;61(20):7507-17. Cancer Res. 2001. PMID: 11606387

10

Synthesis and antitumor activity of novel C-7 paclitaxel ethers: discovery of BMS-184476.

Altstadt TJ, Fairchild CR, Golik J, Johnston KA, Kadow JF, Lee FY, Long BH, Rose WC, Vyas DM, Wong H, Wu MJ, Wittman MD. Altstadt TJ, et al. Among authors: fairchild cr. J Med Chem. 2001 Dec 20;44(26):4577-83. doi: 10.1021/jm0102607. J Med Chem. 2001. PMID: 11741476

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters